BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28577624)

  • 21. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
    Guo F; Hirth JM; Berenson AB
    J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of abnormal cervical cancer screening outcomes among screening-compliant women in the United States.
    Chido-Amajuoyi OG; Shete S
    Am J Obstet Gynecol; 2019 Jul; 221(1):75-77. PubMed ID: 31078510
    [No Abstract]   [Full Text] [Related]  

  • 23. Human papillomavirus in 2019: An update on cervical cancer prevention and screening guidelines.
    Zhang S; Batur P
    Cleve Clin J Med; 2019 Mar; 86(3):173-178. PubMed ID: 30849035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer: what is the optimal age for routine testing?
    Rob L; Tachezy R; Robova H
    Future Oncol; 2015; 11(8):1137-40. PubMed ID: 25832869
    [No Abstract]   [Full Text] [Related]  

  • 25. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
    Printz C
    Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
    [No Abstract]   [Full Text] [Related]  

  • 26. Attitudes toward cervical cancer screening among women receiving human papillomavirus vaccination in a university-hospital-based community: interim 2-year follow-up results.
    Miyagi E; Sukegawa A; Motoki Y; Kaneko T; Maruyama Y; Asai-Sato M; Numazaki R; Mizushima S; Hirahara F
    J Obstet Gynaecol Res; 2014 Apr; 40(4):1105-13. PubMed ID: 24428631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of the Carolina Framework for Cervical Cancer Prevention.
    Moss JL; McCarthy SH; Gilkey MB; Brewer NT
    Gynecol Oncol; 2014 Mar; 132 Suppl 1(0 1):S33-40. PubMed ID: 24333357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
    Fontaine PL; Saslow D; King VJ
    Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
    [No Abstract]   [Full Text] [Related]  

  • 29. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?
    Kepka D; Berkowitz Z; Yabroff KR; Roland K; Saraiya M
    Sex Transm Infect; 2012 Oct; 88(6):433-5. PubMed ID: 22522751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus, current vaccines, and cervical cancer prevention.
    Teitelman AM; Stringer M; Averbuch T; Witkoski A
    J Obstet Gynecol Neonatal Nurs; 2009; 38(1):69-80. PubMed ID: 19208050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
    Malo TL; Perkins RB; Lee JH; Vadaparampil ST
    Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
    Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
    Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical cancer control in Latin America: A call to action.
    Bychkovsky BL; Ferreyra ME; Strasser-Weippl K; Herold CI; de Lima Lopes G; Dizon DS; Schmeler KM; Del Carmen M; Randall TC; Nogueira-Rodrigues A; de Carvalho Calabrich AF; St Louis J; Vail CM; Goss PE
    Cancer; 2016 Feb; 122(4):502-14. PubMed ID: 26670695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for Cervical Cancer.
    Jin J
    JAMA; 2018 Aug; 320(7):732. PubMed ID: 30140878
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current and future role of screening in the era of HPV vaccination.
    Myers E; Huh WK; Wright JD; Smith JS
    Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years.
    Slomski A
    JAMA; 2020 Nov; 324(20):2017-2018. PubMed ID: 33156325
    [No Abstract]   [Full Text] [Related]  

  • 40. [Summary of the practice guideline 'Prevention and early diagnosis of cervical cancer' of the Dutch College of General Practitioners].
    Janssen PG; Boomsma LJ; Buis PA; Collette C; Boukes FS; Goudswaard AN
    Ned Tijdschr Geneeskd; 2009; 153():A517. PubMed ID: 20051149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.